CTA News

Working closely with Marian Lieschke, Heike Raunow and Kylie Shackleton, CTA’s 2019 Research Manager’s Day was held on 17 October. 18 participants joined this highly productive forum from across [...]

CTA has experienced significant growth over recent years, which has accelerated throughout 2019. Dedicating time to team development activities not only helps to integrate new staff into the wider [...]

Invest Victoria recently profiled the strength of interactions between Cancer Trials Australia and BeiGene, a rapidly growing Chinese biopharmaceutical company, with over 1,700 staff across four continents and more than [...]

CTA announces partnership in delivering coordinated Electronic Document Management for Victorian study sites Cancer Trials Australia (CTA) is pleased to announce a new project funded by the Victorian Comprehensive [...]

The Board of Directors of Cancer Trials Australia (CTA) today announced the appointment of Professor Andrew Scott as Chairperson.This appointment was made by the Board following the resignation of Professor [...]

Cancer Trials Australia (CTA) announced today that South West Healthcare had signed an agreement to join CTA. "Southwest Healthcare located at Warrnambool in Victoria services a large population over South [...]

A new RAF-targeted therapeutic has shown early promise against tumours in Phase 1 trials. Doctors Jayesh Desai (1), Ben Solomon (2) and Hui Gan (3)have established a highly successful collaboration [...]

Cancer Trials Australia (CTA) announced today that the Shepparton Hospital, through Goulburn Valley Health, and Northern Adelaide Cancer Centre Clinical Trials Unit, operating as the Lyell McEwin Hospital, have [...]

Chairman of the Board, Professor Andrew Scott, with great pleasure advised that the next Chief Executive Officer of Cancer Trials Australia (CTA) will be Dr Kurt Lackovic. Professor Scott said [...]

Cancer Trials Australia (CTA) is proud to be part of the successful Cancer Council Victoria (CCV) grant application for the establishment of a cancer clinical trials network across seven [...]

Cancer Trials Australia (CTA) is pleased to announce that Linear Clinical Research has signed a Members Agreement to join the CTA Member Network The CTA network now includes 24 [...]

I am pleased to share the Cancer Trials Australia 2016 Annual Report. Download the 2016 Annual Report Here. 2016 saw growth in CTA membership and corresponding CTA service activity. CTA welcomed [...]

I am pleased to share with you the 2018 Cancer Trials Australia Annual Report. Download the 2018 Annual Report Here. The 2018 calendar year saw growth in both CTA [...]

Cancer Trials Australia (CTA) is pleased to announce execution of a Services Agreement with the VCCC to provide Site Management Services for the VCCC’s Investigator Initiated Trial Program.  Professor [...]

CTA has executed an MOU with ShareRoot Limited (ASX: SRO) to explore the application of ShareRoot’s MediaConsent platform as a tool to improve the dynamics of clinical trial recruitment, patient [...]

Cancer Trials Australia is pleased to announce the addition of our 26th major healthcare provider member, Calvary Central Districts Hospital, located in South Australia. This partnership builds on Calvary's [...]

Due to an improved partnership between South West Healthcare (SWH) and CTA, cancer patients will have greater access to potentially life-saving therapies they may not have otherwise had access to. SWH medical oncologist Ian [...]

I am pleased to share the 2017 Cancer Trials Australia Annual Report. Download the 2017 Annual Report Here. 2017 saw expansion of CTA membership and significant growth in CTA services for [...]

Cancer Trials Australia celebrates their support of 1,000 commercially sponsored clinical trials and the recruitment of 8,000 patients, in conjunction with International Clinical Trials Day on May 21st, 2018 Since [...]

More patients will have access to potentially life-saving cancer therapies as a result of Epworth joining forces with Cancer Trials Australia. With the addition of Epworth, CTA now has [...]

Cancer Trials Australia's CEO, Dr Kurt Lackovic, was recently invited to speak at an international webinar showcasing Melbourne as a premier location for the conduct of Phase 1 clinical trials. Aimed primarily at international [...]